331 related articles for article (PubMed ID: 31593850)
21. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
22. New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.
Di Meo F; Donato S; Di Pardo A; Maglione V; Filosa S; Crispi S
Curr Drug Metab; 2018; 19(6):478-489. PubMed ID: 29623833
[TBL] [Abstract][Full Text] [Related]
23. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
[TBL] [Abstract][Full Text] [Related]
24. The Food-gut Human Axis: The Effects of Diet on Gut Microbiota and Metabolome.
De Angelis M; Garruti G; Minervini F; Bonfrate L; Portincasa P; Gobbetti M
Curr Med Chem; 2019; 26(19):3567-3583. PubMed ID: 28462705
[TBL] [Abstract][Full Text] [Related]
25. Microbiome and diabetes: Where are we now?
Vallianou NG; Stratigou T; Tsagarakis S
Diabetes Res Clin Pract; 2018 Dec; 146():111-118. PubMed ID: 30342053
[TBL] [Abstract][Full Text] [Related]
26. Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in Relationships with Causes and Prevention of Liver Diseases (Review).
Nguepi TIS; Song H
Int J Med Mushrooms; 2020; 22(6):509-519. PubMed ID: 32865893
[TBL] [Abstract][Full Text] [Related]
27. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
28. Prebiotics as a modulator of gut microbiota in paediatric obesity.
Nicolucci AC; Reimer RA
Pediatr Obes; 2017 Aug; 12(4):265-273. PubMed ID: 27072327
[TBL] [Abstract][Full Text] [Related]
29. The Human Gut Microbiota.
Harmsen HJ; de Goffau MC
Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
[TBL] [Abstract][Full Text] [Related]
30. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
Martinez KB; Leone V; Chang EB
Gut Microbes; 2017 Mar; 8(2):130-142. PubMed ID: 28059614
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiome approaches to treat obesity in humans.
Bianchi F; Duque ALRF; Saad SMI; Sivieri K
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
[TBL] [Abstract][Full Text] [Related]
32. Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.
Ganesan K; Chung SK; Vanamala J; Xu B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467295
[TBL] [Abstract][Full Text] [Related]
33. The human gut microbiota and its interactive connections to diet.
Milani C; Ferrario C; Turroni F; Duranti S; Mangifesta M; van Sinderen D; Ventura M
J Hum Nutr Diet; 2016 Oct; 29(5):539-46. PubMed ID: 27161433
[TBL] [Abstract][Full Text] [Related]
34. Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota.
Nie Q; Chen H; Hu J; Fan S; Nie S
Crit Rev Food Sci Nutr; 2019; 59(6):848-863. PubMed ID: 30569745
[TBL] [Abstract][Full Text] [Related]
35. Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
Moraes C; Borges NA; Mafra D
Eur J Nutr; 2016 Aug; 55(5):1813-21. PubMed ID: 26830416
[TBL] [Abstract][Full Text] [Related]
36. The gut microbiome and irritable bowel syndrome: State of art review.
Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
[TBL] [Abstract][Full Text] [Related]
37. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.
Serino M
J Mol Biol; 2018 Mar; 430(5):581-590. PubMed ID: 29374557
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota and central nervous system development.
Principi N; Esposito S
J Infect; 2016 Dec; 73(6):536-546. PubMed ID: 27725185
[TBL] [Abstract][Full Text] [Related]
39. Dysbiosis in gastrointestinal disorders.
Chang C; Lin H
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):3-15. PubMed ID: 27048892
[TBL] [Abstract][Full Text] [Related]
40. Interindividual variability in gut microbiota and host response to dietary interventions.
Healey GR; Murphy R; Brough L; Butts CA; Coad J
Nutr Rev; 2017 Dec; 75(12):1059-1080. PubMed ID: 29190368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
